In contrast, SHP2 tyrosine phosphatase converts parafibromin from a tumor suppressor to an oncogenic driver by its interaction with and subsequent stablization of β-catenin to upregulate expression of Wnt target genes, including cyclin D1 and c-myc [27]. The gene discussed is MYC; the disease is neoplasm.